The life sciences industry places a premium on innovation at the highest levels, whether that's in cutting-edge scientific discovery or the complex business transactions driving the industry forward today. Morrison & Foerster's Global Life Sciences Practice is comprised of corporate, transactional, intellectual property, and litigation attorneys who share the value our clients place on this marriage of scientific and business success. We bring superior technical knowledge and business experience for our clients working at the pinnacle of innovation.
We represent more than 600 life sciences companies, research institutions, and venture capital funds and investments banks that finance them. Our practice is comprised of over 180 lawyers around the world— in the locations that matter most to this industry such as Palo Alto, San Diego, and San Francisco; in emerging global markets in Shanghai, Beijing, and Hong Kong; in Japan; in Los Angeles and Sacramento; on the East coast in Northern Virginia and Washington, DC; and in key financial markets in New York and London, with reach into Europe’s prime life sciences centers.
We have cultivated a practice that, like our clients' businesses, is driven by science. We count among our practitioners 43 PhDs and 35 master's degrees in relevant scientific disciplines. Our knowledge and superior experience in the pharmaceutical, biologics, diagnostics, personalized medicine, medical device, medicinal chemicals, and vaccine fields means that we understand the complex technologies at the heart of our clients' businesses.
Among our resources is one of the largest and most recognized patent practices devoted to life sciences of any full-service law firm, with attorneys who have been involved in the development of the life sciences industry for decades. With deep understanding of how patents fit into a company's larger business model and commercial strategy, our patent attorneys assist clients with developing and monetizing their patent portfolios, crafting an IP strategy that aligns with their business objectives and goals, and providing counsel to ensure our clients' remain competitive in the industry.
It's this combination of scientific prowess and the acumen of our business lawyers and litigators that sets our practice apart. Our corporate attorneys advise life sciences companies on issues involving corporate governance and formation, mergers and acquisitions, public offerings, and public and private debt and equity financing transactions. Since 2004, we have represented life sciences clients in more than 100 venture capital financings valued in total at over $1 billion and completed more than 100 public finance and M&A transactions in the life sciences sector. Our technology transactions attorneys are leaders in structuring and negotiating licensing and strategic collaboration agreements; joint ventures; manufacturing, supply and distribution agreements; marketing agreements; technology transfers; and pre-clinical and clinical trial arrangements.
Our life sciences litigators are extolled for their work on IP, product liability, employment and labor, appellate, securities, antitrust, white collar criminal defense, trade secrets, and commercial litigation matters. Aggressively defending our clients' interests, our team is among the most active litigation department in the world and is renowned in the courtroom and, whenever possible, for keeping our clients out of the courtroom.
Our practice is truly global – one of very few firms that can say that. Our life sciences team includes attorneys across the U.S., Europe, and throughout Asia. In Japan, our size and depth of practice are unparalleled by any other international law firm. We represent some of the largest and most active participants in the Japanese biotechnology, medical technology, and pharmaceutical industries, as well as counseling both Japanese and international clients on work related to emerging life sciences companies in Japan and around the world. In China, we are helping clients enter, expand within, or grow outside of the Chinese life sciences market; we are proud to be the only firm ranked by third-party organizations in Asia and China in all of the following areas: China Life Sciences, Global Life Sciences, Global Intellectual Property and Global Technology, M&A, Private Equity, and Venture Capital. Finally, our team in the UK offers unrivalled transactional expertise and is recognized as having "the best depth of life sciences industry knowledge in London" (Legal 500 UK 2010).
MoFo is on the cutting edge of the global interplay between science and business. With our depth of technological expertise, wealth of business insight, renowned legal skill, and global presence, our attorneys are helping clients strike the balance between innovative discovery and purposeful business planning to assure their continued success.